| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
5e-16 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-15 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-12 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-06 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-06 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.23 |
1e-05 |
| mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
6e-05 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
9e-05 |